Tag Archive for: PES 2025

Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal is Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in PWS (Study C614)

Long-term Administration of Diazoxide Choline Extended-Release (DCCR) Tablets in People with Prader-Willi Syndrome: Changes in Lean Body Mass and Lean Mass Index

Pediatric Endocrine Society, 2025